Towards Response ADAptive Radiotherapy for organ preservation for intermediate-risk rectal cancer (preRADAR): protocol of a phase I dose-escalation trial
Abstract:IntroductionOrgan preservation is associated with superior functional outcome and quality of life (QoL) compared with total mesorectal excision (TME) for rectal cancer. Only 10% of patients are eligible for organ preservation following short-course radiotherapy (SCRT, 25 Gy in five fractions) and a prolonged interval (4–8 weeks) to response evaluation. The organ preservation rate could potentially be increased by dose-escalated radiotherapy. Online adaptive magnetic resonance-guided radiotherapy (MRgRT) is ant… Show more
“…Our findings support the investigation of further dose escalation or boosting strategies with MR-guided RT systems, with the aim to enhance treatment efficacy and organ-preserving treatment approaches, while maintaining a good QoL. Several such studies are ongoing and the results are eagerly anticipated (e.g., NCT04808323, NCT05916040, NCT05108428, NCT05338866) [42] .…”
Section: Discussionsupporting
confidence: 69%
“…Therefore, it is expected that the use of MR-guided RT systems further reduces toxicity and improves patient outcomes, and enable dose escalation while preserving QoL. This is currently being investigated in the preRADAR trial [42] .…”
“…Our findings support the investigation of further dose escalation or boosting strategies with MR-guided RT systems, with the aim to enhance treatment efficacy and organ-preserving treatment approaches, while maintaining a good QoL. Several such studies are ongoing and the results are eagerly anticipated (e.g., NCT04808323, NCT05916040, NCT05108428, NCT05338866) [42] .…”
Section: Discussionsupporting
confidence: 69%
“…Therefore, it is expected that the use of MR-guided RT systems further reduces toxicity and improves patient outcomes, and enable dose escalation while preserving QoL. This is currently being investigated in the preRADAR trial [42] .…”
“…Radiation-induced toxicity restricts the tumor's dose, thereby limiting the ability of radiotherapy to suppress tumor development. Furthermore, radiotherapy's prolonged toxicity critically impairs patients' mental and physical health [2]. Nevertheless, the main drawback of RT is that while it is intended to deliver a lethal dose to cancerous cells, exposure to those radiations can damage healthy tissues and cause serious health problems in the short and long term.…”
In traditional treatment modalities and standard clinical practices, FLASH radiotherapy (FL-RT) administers radiation therapy at an exceptionally high dosage rate. When compared to standard dose rate radiation therapy, numerous preclinical investigations have demonstrated that FL-RT provides similar benefits in conserving normal tissue while maintaining equal antitumor efficacy, a phenomenon possible due to the 'FLASH effect' (FE) of FL-RT. The methodologies involve proton radiotherapy, intensity-modulated radiation treatment, and managing high-throughput damage by radiation to solid tissues. Recent results from animal studies indicate that FL-RT can reduce radiation-induced tissue damage, significantly enhancing anticancer potency. Focusing on the potential benefits of FL proton beam treatment in the years to come, this review details the FL-RT research that has been done so far and the existing theories illuminating the FL effects. This subject remains of interest, with many issues still needing to be answered. We offer a brief review to emphasize a few of the key efforts and difficulties in moving FL radiation research forward. The existing research state of FL-RT, its affecting variables, and its different specific impacts are presented in this current review. Key topics discussed include the biochemical mechanism during FL therapy, beam sources for FL therapy, the FL effect on immunity, clinical and preclinical studies on the protective effect of FL therapy, and parameters for effective FL therapy.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.